China Health Group (HKSE:00673) 3-Year EBITDA Growth Rate : 0.00% (As of Sep. 2023)

View and export this data going back to 1996. Start your Free Trial

What is China Health Group 3-Year EBITDA Growth Rate?

China Health Group's EBITDA per Share for the six months ended in Sep. 2023 was HK$-0.04.

During the past 5 years, the average EBITDA Per Share Growth Rate was 20.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of China Health Group was 64.40% per year. The lowest was -140.20% per year. And the median was 29.20% per year.

Competitive Comparison of China Health Group's 3-Year EBITDA Growth Rate

For the Medical Distribution subindustry, China Health Group's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

China Health Group's 3-Year EBITDA Growth Rate Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, China Health Group's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where China Health Group's 3-Year EBITDA Growth Rate falls into.

China Health Group 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

China Health Group (HKSE:00673) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

China Health Group 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of China Health Group's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

China Health Group (HKSE:00673) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » China Health Group Ltd (HKSE:00673) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

141 Des Voeux Road, Unit 801, 8th Floor, China Insurance Group Building, Central, Hong Kong, HKG

Website

http://www.ch-groups.com

China Health Group Ltd is an investment holding company. It is principally engaged in the distribution and service of medical equipment and consumables, provision of hospital operation and management service, and business factoring. It operates in the business in three segments Distribution and service in medical equipment and consumables; Hospital operation and management services and Business factoring service. It derives a majority of revenue from the Distribution and service in the medical equipment and consumables segment. Geographically the group's locations are located in the PRC.

Executives

Treasure Wagon Limited	2101 Beneficial owner
Zhang Fan	2201 Interest of corporation controlled by you
Best Robust Ventures Limited	2101 Beneficial owner
Sun Chunlei	2201 Interest of corporation controlled by you
Yang Huijun	2201 Interest of corporation controlled by you
Chg Victory Limited	2301 Trustee
Coral Point Global Limited	2101 Beneficial owner
Ye Zhankun	2201 Interest of corporation controlled by you

China Health Group (HKSE:00673) Headlines

No Headlines